Company

Company

Overview

NaNotics is a Delaware LLC with headquarters in Mill Valley, CA, just north of San Francisco. NaNotics is developing an advanced nanomedical platform for treating major human and animal diseases. Our management team and Scientific Advisory Board members are profiled below, and our funding history is here. The company leverages multiple vendor and joint development relationships, especially for nano fabrication and design of capture agents. We are open to additional vendors and partnerships so please reach out if you feel you have something to offer.

Management

Founder - CEO

Lou Hawthorne

Co-founder - CTO

John Dodgson, PhD

CFO

Song Schreiber, MS, MBA

CSO

Graeme Currie, PhD

VP of Veterinary R & D

Michael Levenson, VMD

CMO

Keith Block, MD

Founder - CEO

Lou Hawthorne

  • NaNot inventor
  • BA, Princeton, 1983
  • Numerous patents/pending
  • Commercialized cloning
  • Co-founded Viagen, acquired by Intrexon (XON)
  • Embryology: 1997-2008
  • Cancer R&D since 2008
  • Very experienced with AI, software design & media
  • Skilled team builder/manager

Co-founder - CTO

John Dodgson, PhD

  • NaNotics co-founder
  • PhD, Newcastle University (physical chemistry)
  • Expert in micro & nano bio-engineering
  • IP creation (30+ patents), analysis & drafting
  • Very familiar with cancer immunotherapy & pheresis
  • Pioneer in microfluidics, especially as applied to cloning & IVF

CFO

Song Schreiber, MS, MBA

  • University of California Santa Cruz
  • Managed law office of Mayor of San Francisco
  • Managed multimillion-dollar revenue & investments
  • Extensive political & legal strategic experience
  • Extensive experience with pharma & healthcare companies & CEOs

CSO

Graeme Currie, PhD

  • PhD, Aston University, UK
  • 25 years drug development
  • Worked on drugs for AMD/ DME, oncology, hepatitis B, herpes simplex virus, etc.
  • Primary clinical lead on 3 FDA-approved therapeutics
  • Dynavax, Regeneron, Sepracor, PDL, Gilead
  • Led multi-center/country trials with budgets >$100m

VP of Veterinary R & D

Michael Levenson, VMD

  • VMD, University of Pennsylvania, Philadelphia, PA
  • Immunotherapy research and canine clinical trials experience
  • Brings a translational medicine “one health” approach to nanoparticle immunotherapy R&D
  • Practicing emergency veterinarian (Marin County, CA) with clinical focus in critical care medicine, surgery, and oncology

CMO

Keith Block, MD

  • MD, University of Miami
  • 35 years integrative oncology
  • Medical Dir, Block Center for Integrative Cancer Treatment
  • Adjunct Professor, University of Illinois at Chicago
  • Editor-in-Chief, Integrative Cancer Therapies (SagePub)
  • Editorial Board, Physicians Data Query Cancer CAM, National Cancer Institute

Advisory Board

Heiko Rieger, PhD

Stephan Lensky, PhD

Kevin Perrott, PhD

Margaretta Colangelo

Mitch Harman,
 MD, PhD

Mike Eaton, PhD

Wayne Jonas, MD

Shazib Pervaiz, MBBS, PhD

Brian Kennedy, PhD

Aubrey de Grey, PhD

Jonathan Milner, PhD

Heiko Rieger, PhD

  • Professor of Theoretical Physics, Saarland University, Germany
  • Expert: Tumor Modeling

Stephan Lensky, PhD

  • Chief Operating and Chief Business Officer of EpimAb

Kevin Perrott, PhD

  • Scientist, Buck Institute SENS Research Foundation
  • Exec. Director, Methuselah Prize
  • President, Global Healthspan Policy Institute

Margaretta Colangelo

  • Co-founder and Managing Director of Deep Knowledge Group
  • Co-founder and Managing Partner of Longevity Capital
  • Co-founder Deep Knowledge Analytics
  • Co-founder Aging Analytics Agency
  • Co-founder Longevity Bank
  • Co-founder Jthereum
  • President U1 Technologies
  • Over 30 years of experience in executive management in software companies in Silicon Valley
  • Author of over 100 articles on AI, DeepTech, and The Longevity Industry
  • Co-author of Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History

Mitch Harman,
 MD, PhD

  • Chief, Endocrinology Section, Department of Medicine at VA, National Institute on Aging
  • Former Chief, Laboratory of Clinical Investigation (LCI)

Mike Eaton, PhD

  • Professor, Nottingham University
  • Charter Executive Board Member, European Technology Platform for Nanomedicine

Wayne Jonas, MD

  • Integrative Health Expert, Family Physician, Researcher, and Author
  • Former Director NIH Office of Alternative Medicine
  • Former Director World Health Organization Center for Traditional Medicine
  • Former Director of Medical Research Fellowship at Walter Reed Army Institute of Research
  • Retired Lt. Colonel United States Army Medical Corps
  • Practicing Family Physician at Fort Belvoir Community Hospital Pain Clinic
  • Clinical Professor of Family Medicine, Georgetown University
  • Executive Director of Samueli Integrative Health Programs

Shazib Pervaiz, MBBS, PhD

  • Professor, Yong Loo Lin School of Medicine, NUS
  • Expert: Cancer Cell Signals
  • Fellowships: Harvard Medical, Mass General

Brian Kennedy, PhD

  • CEO, Buck Institute for Research on Aging
  • Professor in Medicine & Healthy Aging, National University Singapore

Aubrey de Grey, PhD

  • CSO, SENS Research Foundation International
  • Expert: Aging

Jonathan Milner, PhD

  • Founder, Abcam, PLC
  • Investor in 40 companies
    (3 successful IPOs)

Directors

[Under NDA]

Founder - CEO

Lou Hawthorne

[Under NDA]

Founder - CEO

Lou Hawthorne

  • NaNot inventor
  • BA, Princeton, 1983
  • Numerous patents/pending
  • Commercialized cloning
  • Co-founded Viagen, acquired by Intrexon (XON)
  • Embryology: 1997-2008
  • Cancer R&D since 2008
  • Very experienced with AI, software design & media
  • Skilled team builder/manager

Careers

Open Positions

None at this time.